Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Whereas studies involving animal models of cardiovascular disease demonstrated that resveratrol is able to inhibit hypertrophic growth, the mechanisms involved have not been elucidated. Because studies in cells other than cardiomyocytes revealed that AMP-activated protein kinase (AMPK) and Akt are affected by resveratrol, we hypothesized that resveratrol prevents cardiac myocyte hypertrophy via these two kinase systems. Herein, we demonstrate that resveratrol reduces phenylephrine-induced protein synthesis and cell growth in rat cardiac myocytes via alterations of intracellular pathways involved in controlling protein synthesis (p70S6 kinase and eukaryotic elongation factor-2). Additionally, we demonstrate that resveratrol negatively regulates the calcineurin-nuclear factor of activated T cells pathway thus modifying a critical component of the transcriptional mechanism involved in pathological cardiac hypertrophy. Our data also indicate that these effects of resveratrol are mediated via AMPK activation and Akt inhibition, and in the case of AMPK, is dependent on the presence of the AMPK kinase, LKB1. Taken together, our data suggest that resveratrol exerts anti-hypertrophic effects by activating AMPK via LKB1 and inhibiting Akt, thus suppressing protein synthesis and gene transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Resveratrol treatment activates SIRT1, PGC-1α and AMPK [29, 145-148] and inhibits AKT [149] (Figure 4).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [149]
In the citing paper
“The loss of AMPK activity is believed to be pro-hypertrophic because lines of molecular signaling pathways that control cell growth are attenuated by AMPK activation [197,198,199].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M.-H., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 478
RetractedInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Shiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 939
SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase
Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802187200 · Cited by 778
Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy
Wilkins, B. J., Dai, Y.-S., Bueno, O. F., Parsons, S. A., Xu, J., Plank, D. M., Jones, F., Kimball, T. R., & Molkentin, J. D. (2004) · Circulation Research · doi:10.1161/01.res.0000109415.17511.18 · Cited by 761
Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M., Sato, K., Inoue, T., Funahashi, T., & Walsh, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310389200 · Cited by 759
Resveratrol stimulates AMP kinase activity in neurons
Dasgupta, B., & Milbrandt, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610068104 · Cited by 723
Adiponectin-mediated modulation of hypertrophic signals in the heart
Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D. R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K., et al. (2004) · Nature Medicine · doi:10.1038/nm1137 · Cited by 671
Research works printed but not linked: 2
- Liu, Z., Song, Y., Zhang, X., Liu, Z., Zhang, W., Mao, W., Wang, W., Cui, W., Zhang, X., Jia, X., Li, N., Han, C., and Liu, C. (2005) Clin. Exp. Phar- macol. Physiol. 32, 1049 -1054
- Hou, X., Xu, S., Maitland-Toolan, K. A., Sato, K., Jiang, B., Ido, Y., Lan, F., Walsh, K., Wierzbicki, M., Verbeuren, T. J., Cohen, R. A., and Zang, M. (2008) J. Biol. Chem.
Cited by
Items 201–244 of 244
Saravanan, J. A. M., Ali, A., & Katare, R. (2025) · The FASEB Journal · doi:10.1096/fj.202501226rr · Cited by 8
“Thus, AMPK is crucial in counteracting cardiac hypertrophy [56–58].”
Paszternák, A., Varga, K., Gyöngyössy, R., Tarnóczi, K., Sikur, N., Szökő, É., & Tábi, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110787 · Cited by 5
Lambert, K., Demion, M., Lagacé, J., Hokayem, M., Dass, M., Virsolvy, A., Jover, B. F., Bourret, A., & Bisbal, C. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108522 · Cited by 7
Kindlovits, R., Bertoldi, J., Rocha, H. N. M., Bento‐Bernardes, T., Gomes, J. L. P., de Oliveira, E. M., Muniz, I. C., Pereira, J. F., Fernandes‐Santos, C., Rocha, N. G., et al. (2021) · Experimental Physiology · doi:10.1113/ep088845 · Cited by 5
Resveratrol: Effects on Lipids and Cardiovascular Risk
Cherniack, E. P., & Troen, B. R. (2013) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0289-2 · Cited by 7
“These data are consistent with previous reports that resveratrol increases AMPK in cardiac myocytes [36] and stimulates PGC-1 α activity in mice leading to mitochondrial biogenesis [52].”
BackgroundResultGorący, A., Rosik, J., Szostak, J., Szostak, B., Retfiński, S., Machaj, F., & Pawlik, A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2240021 · Cited by 5
Calorie Restriction Mimetics and Aging
Morris, B. J. (2010) · Springer eBooks · doi:10.1007/978-90-481-8556-6_9 · Cited by 5
Chen, J., Zhang, L., Xie, T., Zhang, X. L., Pan, C., Sun, F., Li, W., Sun, Z., & Dong, D.-L. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.12.040 · Cited by 6
“Activation of AMPK or inhibition of Akt and STAT3 inhibits heart hypertrophy 33-36 .”
Resveratrol Emerges as a Miracle Cardioprotective Phytochemical Polyphenol and Nutraceutical
Selvaraju, V., Joshi, M., Kotha, S. R., Parinandi, N. L., & Maulik, N. (2013) · CRC Press eBooks · doi:10.1201/b14663-26 · Cited by 6
Umehara, H., & Asai, A. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.805 · Cited by 4
Krzyżewska, A., Baranowska‐Kuczko, M., & Kozłowska, H. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70347 · Cited by 3
“In addition, p70S6K activation promotes cardiac hypertrophy and remodelling (Chan et al., 2008).”
Strunz, C. M. C., Roggério, A., Cruz, P. L., Benvenuti, L. A., Irigoyen, M. C., & Mansur, A. D. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041672 · Cited by 4
The Role of AMPK in the Control of Cardiac Hypertrophy
Byrne, N. J., Sung, M. M. Y., & Dyck, J. R. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1227-8_13 · Cited by 5
Self-citationResveratrol Alleviates Some Cardiac Dysfunction Indexes in an SHR Model of Essential Hypertension
WU, J. M. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.209 · Cited by 2
Potent Beneficial Effects of Vegetables and Fruits on Cardiovascular Diseases
Nalini, N., & Santiago, J. V. A. (2013) · CRC Press eBooks · doi:10.1201/b14663-27 · Cited by 2
Vafaee, R., Soori, H., Hedayati, M., & Hatamabadi, H. (2019) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v7i1.330 · Cited by 2
“revealed the inhibitory effect of REV on cardiac hypertrophy in 2008 (15).”
BackgroundRole of Sirtuins in Regulation of Cardiac Adaptation Associated with Hypertrophy
Pillai, V. B., & Gupta, M. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5203-4_19 · Cited by 2
The Role of Autophagy in Heart Disease
Mohiuddin, O., Abraham, S., Zhang, H., & Ruiz‐Velasco, A. (2024) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2024.100021 · Cited by 1
Hsu, C., & Tain, Y. (2026) · Antioxidants · doi:10.3390/antiox15040509 · Cited by 2
مکانیسمهای سلولی مولکولی اثرات رزوراترول در قلب وعروق
هاشمیان, م., & زند, ح. (2015) · مجله علمی دانشگاه علوم پزشکی بابل · doi:10.22088/jbums.17.4.51 · Cited by 1
“Cardiovascular Hypertrophy: Several studies have proposed that resveratrol could slow down the process of aorta and cardiac hypertrophy (55, 56) by reducing the blood pressure, exerting anti-hypertrophic effects on AMPK signaling pathway and inhibiting Akt signaling pathway (57, 58).”
BackgroundCellular and Molecular Mechanisms of Resveratrol and Its Derivatives
Stuart, J. A., & Robb, E. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6968-1_3 · Cited by 1
Obesity and Cardiovascular Disease: Impact of Resveratrol as a Therapeutic
Louis, X. L., Krishnan, S. K., Wigle, J. T., & Netticadan, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_15 · Cited by 1
Molecular Mechanisms of AMPK- and Akt- Dependent Survival of Glucose-Starved Cardiac Myocytes
Chopra, I. (2012) · Cited by 1
Takano, A. P. C. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2011.tde-09022012-112005
Palomer, X. (2009) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(09)71135-0
E013 Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells
de Brito, P. M., Devillard, R., Nègre‐Salvayre, A., Salvayre, R., & Augè, N. (2009) · Archives of cardiovascular diseases · doi:10.1016/s1875-2136(09)72252-1
Palomer, X. (2011) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2011.05.001
Banek, C. T. (2014) · Scholars' Bank (University of Oregon)
AMPK and Metabolic Remodeling in Cardiac Disease
Pulinilkunnil, T., Nagendran, J., & Dyck, J. R. B. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_5 · Cited by 1
Self-citationHamza, S. M., Sung, M. M. Y., & Dyck, J. R. B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-5930-9_14
Self-citationFord, R. J. (2011) · UWSpace (University of Waterloo)
Juhász, V. (2017) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.4039
The Role of Palmitoleate in Hypertension and Cardiac Hypertrophy
Bairwa, S. C. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3p26qh7t
Investigating the effects of bronchodilator induced cardiotoxicity
Cassambai, S. (2018)
Role of Natural Compounds in Inflammation and Inflammatory-Related Diseases
Μaione, F. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-553-9
Targeting autophagy: lifestyle and pharmacological approaches
Briones‐Herrera, A., Gómez‐Sierra, T., Martínez‐Klimova, E., Bellido, B., & Pedraza‐Chaverrí, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822003-0.00010-3
The Role of Subterminal Hydroxyeicosatetraenoic Acids in the Pathogenesis of Cardiac Hypertrophy
Shoieb, S. M. (2021) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-8b1m-6p97
Vitamins, minerals, and nutraceuticals
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00004-7
Brawerman, G. M. (2018) · Mspace (University of Manitoba)
Effets des polyphénols de baies sur le déclin cognitif lié au vieillissement chez la souris
Bensalem, J. (2014) · theses.fr (ABES) · doi:10.70675/ac65ac13zbca9z4d32zaef9za6966d5794e1 · Cited by 2
Gao, M., Li, L., Li, L., Wu, H., Wu, Y., & Fu, L. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10935-8
Active component and protective effects of Cornus officinalis on cardiomyocyte hypertrophy via AMPK
陈克芳, Chen, K., Pan, A., Kang, M., Zhang, B., Li, J., & Chen, L. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100634
Metadata
- Authors
- Chan, A. Y. M., Dolinsky, V. W., Soltys, C.-L. M., Viollet, B., Baksh, S., Light, P. E., & Dyck, J. R. B.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Dyck, Jason R.B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 283
- Issue
- 35
- Pages
- 24194-24201
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC3259789
- OpenAlex
- W2091412980
- Cited by
- 244
- References
- 40
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 5 · 2023: 6 · 2022: 7 · 2021: 8 · 2020: 12 · 2019: 10 · 2018: 16 · 2017: 15 · 2016: 14 · 2015: 19 · 2014: 15 · 2013: 18 · 2012: 21
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4445 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- European Commission (LSHMCT-2004-005272)
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
- Alberta Heritage Foundation for Medical Research
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- resveratrol, cardiac hypertrophy, AMPK, Akt, LKB1, cardiomyocytes, p70 S6 kinase, elongation factor 2, calcineurin/NFAT signaling, protein synthesis, phenylephrine, gene transcription
- MeSH terms
- Resveratrol, AMP-Activated Protein Kinase Kinases, Animals, Cardiotonic Agents, Cells, Cultured, Enzyme Activation, Enzyme Inhibitors, Cardiomegaly, Multienzyme Complexes, Phenylephrine, Stilbenes, Transcription, Genetic, Protein Biosynthesis, Protein Serine-Threonine Kinases, Peptide Elongation Factor 2, Myocytes, Cardiac, Ribosomal Protein S6 Kinases, 70-kDa, Proto-Oncogene Proteins c-akt, Mice, Rats, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.